Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

783 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG2 cancer cells.
Sabzichi M, Oladpour O, Mohammadian J, Rashidi M, Hosseinzadeh M, Mardomi A, Ramezani B, Ghorbani M, Ramezani F. Sabzichi M, et al. Among authors: ghorbani m. Naunyn Schmiedebergs Arch Pharmacol. 2021 Dec;394(12):2429-2439. doi: 10.1007/s00210-021-02164-5. Epub 2021 Sep 30. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 34590187
Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism.
Maroufi NF, Vahedian V, Mazrakhondi SAM, Kooti W, Khiavy HA, Bazzaz R, Ramezani F, Pirouzpanah SM, Ghorbani M, Akbarzadeh M, Hajipour H, Ghanbarzadeh S, Sabzichi M. Maroufi NF, et al. Among authors: ghorbani m. Naunyn Schmiedebergs Arch Pharmacol. 2020 Jan;393(1):1-11. doi: 10.1007/s00210-019-01692-5. Epub 2019 Aug 2. Naunyn Schmiedebergs Arch Pharmacol. 2020. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec 10. doi: 10.1007/s00210-024-03709-0 PMID: 31372697 Retracted.
Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis.
Khaki-Khatibi F, Ghorbani M, Sabzichi M, Ramezani F, Mohammadian J. Khaki-Khatibi F, et al. Among authors: ghorbani m. Biomed Pharmacother. 2019 Jan;109:1240-1248. doi: 10.1016/j.biopha.2018.10.183. Epub 2018 Nov 7. Biomed Pharmacother. 2019. Retraction in: Biomed Pharmacother. 2025 Jan;182:117775. doi: 10.1016/j.biopha.2024.117775 PMID: 30551374 Free article. Retracted.
783 results